Threshold Pharmaceuticals, Inc (THLD): Opiniones

doblé posición el día de bajada.

un saludo para el tí y el ''fenomeno''

ÁNIMOS!!

Yo tb.
gracias por habernos dado un poco de luz ese negra día.
Un abrazo y que regreses con fuerzas renovadas Monstruo.

Buena noticia:

http://www.streetinsider.com/New+Coverage/Maxim+Group+Starts+Threshold+Pharmaceuticals+%28THLD%29+at+Buy/7740711.html?si_client=st

Saludos!!!!

10$ de PO ..

Si, tiene un PO medio de 13$.

Con el PO de 13$ nos iríamos a un mas 70% respecto ahora mismo; y con manos fuertes entrando despues de la caida, a ver si tira para arriba y cierra el GAP del otro día.

De momento no creo que rebajen el PO el resto de agencias, porque nos joderían vivos.

Recorto un trozo de un articulo sobre THLD que me ha llamado la atención.
3. Cash burn
In a realistic sense, Threshold is still years away from an FDA approval and commercializing its combination drug, TH-302. In the meantime, concurrently running 11 clinical trials is extremely expensive, and even having a stellar marketing partner like Merck KGaA isn't going to guarantee enough cash to successfully run every trial. Therefore, it's likely that Threshold will need to raise cash through share offerings in the near future in order to shore up its balance sheet prior to moving forward with multiple trials in 2013.

As of Threshold's most recently ended quarter, the company boasted $66.5 million in cash with no debt. However, in an average year it's not unreasonable to expect Threshold to burn through $20 million to $30 million in cash, even with various milestone payments from Merck KGaA. In short, I'd expect a share offering to come shortly -- especially with the stock near a 52-week high.
Saludos